stella
beta
Plasma Metabolomics as a Tool to Distinguish PET-positive Malignant From PET-positive Benign Nodules — Stella
Home
/
Solitary Pulmonary Nodules
/
Plasma Metabolomics as a Tool to Distinguish PET-positive Malignant From PET-positive Benign Nodules
View on ClinicalTrials.gov
Recruiting
Back to Solitary Pulmonary Nodules trials
Plasma Metabolomics as a Tool to Distinguish PET-positive Malignant From PET-positive Benign Nodules
Not a traditional drug trial — this study doesn't follow the standard phase structure.
Trial locations
(1 site)
Belgium
Ziekenhuis Oost-Limburg, Genk, Limburg